Skip to content

Novel Therapeutics

Novel Therapeutics is an incubator space affiliated with the University of California San Diego, focusing on biotechnology and medical research, particularly in cancer treatment and research commercialization.

Focus sectors
Biotech, Healthcare
Recorded regions
United States
Novel Therapeutics
SectionOverview
Get Pro
Actions
Get Pro

Online destinations

Find Novel Therapeutics online

Public destinations are grouped by their documented relationship to the organization. A listed link does not by itself prove ownership or control.

Official links

Destinations the organization presents as part of its public presence.

Overview

The Center for Novel Therapeutics (CNT) is located at the University of California San Diego's Science Research Park. It was established to promote collaboration among scientists and clinical researchers with the aim of accelerating the development of therapies from research to patient treatment. The facility spans 137,500 square feet and is designed to leverage the expertise of UC San Diego's Moores Cancer Center alongside private sector companies.

Focus

CNT focuses on fostering academic collaboration and technology commercialization in the life sciences sector. It provides resources for entrepreneurs, including incubator space with fully equipped laboratories, to support the development of new technology businesses. The center aims to create an academic-industry drug discovery incubator to enhance public-private partnerships in cancer research and treatment.

Support

CNT offers incubator space with fully equipped laboratories, access to renowned research centers, and resources for technology commercialization to support entrepreneurs in the life sciences sector.

Overlapping documented focus

Similar incubators

Browse all incubators
Quarter Zero logoIncubator

Quarter Zero is an organization focused on empowering young entrepreneurs through education and incubation programs. They aim to equip students with the skills necessary to thrive in a rapidly evolving world.

Superscout Pro

Build a scout record investors can understand.

  • Keep a private deal vault with timestamps
  • Write richer memos and evaluations
  • Compare investor and program fit
  • Manage sources, next actions, and follow-up
$99$249 first year
Superscout Pro
Illustrative
Illustrative scout
Scout profile Structured activity
Memo drafted
Submitted
Following

Superscout documents Novel Therapeutics independently from canonical records and linked sources. Missing facts stay missing.

Sources and known limits

Last reviewed .

Terms, dates, and eligibility can change. Confirm time-sensitive details with the original source.

Stage and region classifications are shown as recorded. Broad labels such as “Global” and category-like stage labels may still need normalization.

Superscout is not affiliated with, endorsed by, or acting on behalf of the organizations documented here.